Browse by author
Lookup NU author(s): Professor Quentin AnsteeORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2022, Springer Nature Limited. Non-alcoholic fatty liver disease (NAFLD) and its inflammatory form, non-alcoholic steatohepatitis (NASH), have quickly risen to become the most prevalent chronic liver disease in the Western world and are risk factors for the development of hepatocellular carcinoma (HCC). HCC is not only one of the most common cancers but is also highly lethal. Nevertheless, there are currently no clinically approved drugs for NAFLD, and NASH-induced HCC poses a unique metabolic microenvironment that may influence responsiveness to certain treatments. Therefore, there is an urgent need to better understand the pathogenesis of this rampant disease to devise new therapies. In this line, preclinical mouse models are crucial tools to investigate mechanisms as well as novel treatment modalities during the pathogenesis of NASH and subsequent HCC in preparation for human clinical trials. Although, there are numerous genetically induced, diet-induced and toxin-induced models of NASH, not all of these models faithfully phenocopy and mirror the human pathology very well. In this Perspective, we shed some light onto the most widely used mouse models of NASH and highlight some of the key advantages and disadvantages of the various models with an emphasis on ‘Western diets’, which are increasingly recognized as some of the best models in recapitulating the human NASH pathology and comorbidities.
Author(s): Gallage S, Avila JEB, Ramadori P, Focaccia E, Rahbari M, Ali A, Malek NP, Anstee QM, Heikenwalder M
Publication type: Article
Publication status: Published
Journal: Nature Metabolism
Year: 2022
Volume: 4
Pages: 1632-1649
Print publication date: 01/12/2022
Online publication date: 20/12/2022
Acceptance date: 26/10/2022
ISSN (electronic): 2522-5812
Publisher: Nature Research
URL: https://doi.org/10.1038/s42255-022-00700-y
DOI: 10.1038/s42255-022-00700-y
Altmetrics provided by Altmetric
